CIK 0001034842 · Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943248524
- Phone
- 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-23 | HANNAH ALISON L. Director | Grant or award | +2,500 | 10,625 | ||
| 2025-05-23 | HANNAH ALISON L. Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2025-05-23 | Frohlich Mark W Director | Grant or award | +1,250 | 1,250 | ||
| 2025-05-23 | Frohlich Mark W Director | Grant or award · Stock Option (Right to Buy) | +1,500 | 1,500 | ||
| 2025-03-17 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +5,625 | 5,625 | ||
| 2025-03-17 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +7,850 | 7,850 | ||
| 2025-03-17 | Santos David A EVP, Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +6,875 | 6,875 | ||
| 2025-03-17 | Santos David A EVP, Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +7,850 | 7,850 | ||
| 2025-03-17 | Rojkjaer Lisa EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +9,375 | 9,375 | ||
| 2025-03-17 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +26,250 | 26,250 | ||
| 2025-03-17 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-03-17 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award · Employee Stock Option (right to buy) | +9,375 | 9,375 | ||
| 2025-03-17 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award · Employee Stock Option (right to buy) | +7,850 | 7,850 | ||
| 2025-03-06 | Frohlich Mark W Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2025-02-05 | Schorno Dean L EVP & Chief Financial Officer | Sale | −1,734 | $21.93 | $38K | 57,235 |
| 2025-02-05 | Santos David A EVP, Chief Commercial Officer | Sale | −1,796 | $21.93 | $39K | 51,704 |
| 2025-02-05 | RODRIGUEZ RAUL R CEO, President | Sale | −4,400 | $21.93 | $96K | 239,454 |
| 2025-02-05 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Sale | −1,339 | $21.93 | $29K | 38,830 |
| 2025-02-04 | Schorno Dean L EVP & Chief Financial Officer | Sale | −2,036 | $20.92 | $43K | 58,969 |
| 2025-02-04 | Santos David A EVP, Chief Commercial Officer | Sale | −2,125 | $20.92 | $44K | 53,500 |
Page 5 of 9 · 176 trades